See more : Schneider Electric S.E. (SU.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Nextgen Biomed Ltd (NXGN.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nextgen Biomed Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Nektar Therapeutics (0UNL.L) Income Statement Analysis – Financial Results
- AGBA Acquisition Limited (AGBA) Income Statement Analysis – Financial Results
- PNB Housing Finance Limited (PNBHOUSING.BO) Income Statement Analysis – Financial Results
- CropEnergies AG (CE2.DE) Income Statement Analysis – Financial Results
- Syncom Formulations (India) Limited (SYNCOMF.NS) Income Statement Analysis – Financial Results
Nextgen Biomed Ltd (NXGN.TA)
About Nextgen Biomed Ltd
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 796.00K | 455.00K | 351.00K | 0.00 | 0.00 | 65.00K | 327.00K | 418.00K | 1.60M | 1.46M | 467.00K |
| General & Administrative | 4.45M | 2.04M | 2.49M | 1.33M | 1.24M | 1.15M | 1.21M | 1.40M | 2.79M | 2.87M | 5.19M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.45M | 2.04M | 2.49M | 1.33M | 1.24M | 1.15M | 1.21M | 1.40M | 2.79M | 2.87M | 5.19M |
| Other Expenses | 1.55M | -4.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 57.00K | -88.00K | 75.00K |
| Operating Expenses | 6.80M | 3.58M | 2.84M | 1.33M | 1.24M | 1.21M | 1.54M | 1.82M | 4.39M | 4.33M | 8.30M |
| Cost & Expenses | 6.80M | 3.58M | 2.84M | 1.33M | 1.24M | 1.21M | 1.54M | 1.82M | 4.39M | 4.33M | 8.30M |
| Interest Income | 30.00K | 29.00K | 307.00K | 31.00K | 26.00K | 0.00 | 32.00K | 16.00K | 2.00K | 14.00K | 15.00K |
| Interest Expense | 0.00 | 64.00K | 22.00K | 1.00K | 1.00K | 59.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.00K | 7.00K | 4.00K | 1.00K | 1.00K | 1.00K | 2.00K | 3.00K | 4.00K | 1.00K | 1.00K |
| EBITDA | -5.25M | -8.51M | -2.53M | -1.30M | -1.24M | -1.21M | -1.50M | -1.81M | -4.38M | -4.33M | -8.30M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -6.80M | -9.32M | -2.84M | -1.33M | -1.24M | -1.21M | -1.54M | -1.82M | -4.39M | -4.33M | -8.30M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -7.40M | 743.00K | 285.00K | 30.00K | 25.00K | -59.00K | 32.00K | 0.00 | 17.00K | -618.00K | 79.00K |
| Income Before Tax | -14.20M | -8.58M | -2.55M | -1.30M | -1.22M | -1.27M | -1.51M | -1.82M | -4.37M | -4.95M | -8.22M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 799.00K | 305.00K | 29.00K | -2.00K | -6.00K | 25.00K | -9.00K | -21.00K | -17.00K | 21.00K |
| Net Income | -14.19M | -8.57M | -2.55M | -1.30M | -1.21M | -1.26M | -1.50M | -1.81M | -4.33M | -4.93M | -8.22M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -1.95 | -0.20 | -0.06 | -0.04 | -0.04 | -0.04 | -0.05 | -0.10 | -0.57 | -1.62 | -3.35 |
| EPS Diluted | -1.95 | -0.20 | -0.06 | -0.04 | -0.04 | -0.04 | -0.05 | -0.10 | -0.57 | -1.40 | -2.93 |
| Weighted Avg Shares Out | 7.26M | 43.35M | 39.68M | 32.52M | 28.99M | 28.99M | 28.99M | 19.02M | 7.65M | 3.05M | 2.45M |
| Weighted Avg Shares Out (Dil) | 7.26M | 43.35M | 39.68M | 32.52M | 28.99M | 28.99M | 28.99M | 19.02M | 7.65M | 3.51M | 2.80M |
No news found for: NXGN.TA
Source: https://incomestatements.info
Category: Stock Reports